Life Science Insights cover art

All Episodes

Life Science Insights — 22 episodes

#
Title
1

Capital Readiness Program (CRP) #1: How Demo Days are Failing Founders and Why CRP is a Better Way, with Heath Naquin

2

Season 2 Epilogue and Season 3 Introduction

3

Everything you Need to Know about SBIR Reauthorization, with Jerry Hollister, BBCetc

4

Payers Don't Care what FDA Considers Safe and Effective, with Erik Harris

5

An Afternoon with a Medtech Guru - Andrew DiMeo Sr., Ph.D. on Design Paradigms, Jars of Marbles, and SBIRs

6

From Accidental Discovery to Infection-Fighting Implants: The Silicon Nitride Story, with Ryan Bock, Ph.D.

7

Fall in Love with the Problem, Not the Solution: Orthopedic Innovation at the Right Stage, with Mohit Prajapati, MBA

8

In Which an Old Dog Learns New Tricks: The Right Way to Use LLMs in Medical Device Development, with Spencer Jones

9

Building Better Clinical Programs, with the Iron CMO, Cellia Habita, MD, PhD

10

Cardiac Arrest Kills 300,000 Americans Annually; Can Better CPR Change That? with Norman Paradis, MD

11

When Physicians Meet AI Engineers in the Elevator: Colorado's Life Science Hub Strategy, with Afshin Safavi, PhD

12

When a Condition Affecting One in Three Women Has No Approved Treatment: Building Solutions, with Peter Pacult, MBA

13

From Recruiting Undercover Linguists to Building Real-time Brain Monitoring for Neurosurgery, with Juliana Buonanno

14

How to Not End Up in Jail if You are an Academic Researcher, with Ann Adams, J.D.

15

Problem-Driven Innovation: The CleoCare Story with Frederico Stock, COO

16

Season 1 - Epilogue

17

From Academic Discovery to a Real Drug Program, with Vinod Vijayakumar, D. Phil

18

When to Spin Out a University Technology, with Rachel Riley, Ph.D.

19

What Founding a Medtech Company Is Really Like, with Eric Sugalski

20

Why Medical Products Fail and How Design Controls Can Prevent It, with John Crombie

21

CMC, Toxicology, and What Investors Really Evaluate, with Michael Silvon, Ph.D., MBA

22

How to Engage FDA Strategically: Mitchell Glass, M.D.